Efficacy and safety of programmed cell death protein 1/programmed death-ligand 1 inhibitors combined with chemotherapy for breast cancer: a systematic review and meta-analysis
程序性细胞死亡蛋白1/程序性死亡配体1抑制剂联合化疗治疗乳腺癌的疗效和安全性:系统评价和荟萃分析
期刊:Translational Cancer Research
影响因子:1.7
doi:10.21037/tcr-2025-1949
Xiao, Geqiong; Bi, Chenchen; Cai, Zhidong; Yan, Junwei; Lv, Tingting; Wang, Xiang; Ding, Haigang; Ding, Zhinan; Xuan, Yuying; Chen, Junxia; Liu, Zheng